Efficacy and safety of bortezomib in the treatment of active antibody-mediated rejection in adult kidney-transplant recipients: A single-center retrospective study

Introduction: The management of active antibody-mediated rejection (ABMR) is evolving, and optimal treatment remains uncertain due to incomplete understanding of pathogenesis. Bortezomib is found to be useful in the treatment of active ABMR. We studied the efficacy and safety of bortezomib in renal-...

Full description

Bibliographic Details
Main Authors: Dharmendra Bhadauria, Sai Kumar, Monika Yachha, Anupma Kaul, Manas Ranjan Patel, Ravi Shankar Kushwaha, Manas R Behera, Narayan Prasad
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Transplantation
Subjects:
Online Access:http://www.ijtonline.in/article.asp?issn=2212-0017;year=2022;volume=16;issue=1;spage=101;epage=106;aulast=Bhadauria